Patents by Inventor Arne Astrup

Arne Astrup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180038869
    Abstract: A method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject, said method comprising determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the biomarkers are selected from fructosamine and factor VII.
    Type: Application
    Filed: June 29, 2015
    Publication date: February 8, 2018
    Inventors: Jorg Hager, Irina Irincheeva, Armand Valsesia, Wim Saris, Arne Astrup
  • Patent number: 9848625
    Abstract: The present invention relates to methods for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing non-fat energy uptake in the gastrointestinal tract of a mammal in order to prevent a positive non-fat energy balance, weight gain, overweight and obesity, and to induce a negative non-fat energy balance and weight loss in subjects who wish to reduce their body weight. In particular, feed, food and/or beverages and dietary supplements of the present invention comprises mucilage such as flax seed mucilage and/or one or more active compounds of mucilage useful for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing the digestibility of non-fat energy in the gastrointestinal tract of a mammal.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: December 26, 2017
    Assignee: University of Copenhagen
    Inventors: Arne Astrup, Inge Tetens, Mette Kristensen
  • Publication number: 20170173099
    Abstract: The present invention relates to methods for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing non-fat energy uptake in the gastrointestinal tract of a mammal in order to prevent a positive non-fat energy balance, weight gain, overweight and obesity, and to induce a negative non-fat energy balance and weight loss in subjects who wish to reduce their body weight. In particular, feed, food and/or beverages and dietary supplements of the present invention comprises mucilage such as flax seed mucilage and/or one or more active compounds of mucilage useful for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing the digestibility of non-fat energy in the gastrointestinal tract of a mammal.
    Type: Application
    Filed: December 20, 2016
    Publication date: June 22, 2017
    Inventors: Arne ASTRUP, Inge TETENS, Mette KRISTENSEN
  • Publication number: 20150320817
    Abstract: The present invention relates to methods for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing non-fat energy uptake in the gastrointestinal tract of a mammal in order to prevent a positive non-fat energy balance, weight gain, overweight and obesity, and to induce a negative non-fat energy balance and weight loss in subjects who wish to reduce their body weight. In particular, feed, food and/or beverages and dietary supplements of the present invention comprises mucilage such as flax seed 10 mucilage and/or one or more active compounds of mucilage useful for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing the digestibility of non-fat energy in the gastrointestinal tract of a mammal.
    Type: Application
    Filed: May 22, 2015
    Publication date: November 12, 2015
    Inventors: Arne ASTRUP, Inge TETENS, Mette KRISTENSEN
  • Patent number: 9066536
    Abstract: The present invention relates to methods for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing non-fat energy uptake in the gastrointestinal tract of a mammal in order to prevent a positive non-fat energy balance, weight gain, overweight and obesity, and to induce a negative non-fat energy balance and weight loss in subjects who wish to reduce their body weight. In particular, feed, food and/or beverages and dietary supplements of the present invention comprises mucilage such as flax seed mucilage and/or one or more active compounds of mucilage useful for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing the digestibility of non-fat energy in the gastrointestinal tract of a mammal.
    Type: Grant
    Filed: September 12, 2008
    Date of Patent: June 30, 2015
    Assignee: University of Copenhagen
    Inventors: Arne Astrup, Inge Tetens, Mette Kristensen
  • Publication number: 20100261661
    Abstract: The present invention relates to methods for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing non-fat energy uptake in the gastrointestinal tract of a mammal in order to prevent a positive non-fat energy balance, weight gain, over-weight and obesity, and to induce a negative non-fat energy balance and weight loss in subjects who wish to reduce their body weight. In particular, feed, food and/or beverages and dietary supplements of the present invention comprises mucilage such as flax seed mucilage and/or one or more active compounds of mucilage useful for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing the digestibility of non-fat energy in the gastrointestinal tract of a mammal.
    Type: Application
    Filed: September 12, 2008
    Publication date: October 14, 2010
    Applicant: UNIVERSITY OF COPENHAGEN
    Inventors: Arne Astrup, Inge Tetens, Mette Kristensen
  • Publication number: 20080008770
    Abstract: A composition for reducing the weight of a human. The composition is provided in the form of a capsule comprising an effective amount of capsaicin and/or analogs thereof, L-tyrosine, supplemental caffeine and/or and analogs thereof, green tea extract containing catechin and caffeine, and embodiments which include calcium. The invention is also directed toward methods for reducing and maintaining weight of a human using the composition.
    Type: Application
    Filed: September 14, 2007
    Publication date: January 10, 2008
    Inventors: Arne Astrup, Soren Toubro
  • Publication number: 20070292542
    Abstract: The present invention relates to methods for reducing fat uptake in the gastrointestinal tract of a mammal in order to prevent a positive energy balance, weight gain, overweight and obesity, and to induce a negative energy balance and weight loss in subjects who wish to reduce their body weight. In particular, food and/or beverage ingredients and dietary supplements of the present invention comprises flaxseeds useful for increasing faeca fat excretion from the gastrointestinal tract.
    Type: Application
    Filed: May 10, 2005
    Publication date: December 20, 2007
    Inventors: Arne Astrup, Inge Tetens, Agnete Thomsen
  • Publication number: 20070212430
    Abstract: A composition for reducing the weight of a human. The composition is provided in the form of a capsule comprising an effective amount of capsaicin and/or analogs thereof, L-tyrosine, supplemental caffeine and/or and analogs thereof, green tea extract containing catechin and caffeine, and embodiments which include calcium. The invention is also directed toward methods for reducing and maintaining weight of a human using the composition.
    Type: Application
    Filed: May 1, 2007
    Publication date: September 13, 2007
    Inventors: Arne Astrup, Soren Toubro
  • Publication number: 20070202200
    Abstract: A composition for reducing the weight of a human. The composition is provided in the form of a capsule comprising an effective amount of capsaicin and/or analogs thereof, L-tyrosine, supplemental caffeine and/or and analogs thereof, green tea extract containing catechin and caffeine, and embodiments which include calcium. The invention is also directed toward methods for reducing and maintaining weight of a human using the composition.
    Type: Application
    Filed: May 1, 2007
    Publication date: August 30, 2007
    Inventors: Arne Astrup, Soren Toubro
  • Publication number: 20070161568
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: March 5, 2007
    Publication date: July 12, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Jens Holst, Arne Astrup, Martin Judge, Liselotte Knudsen, Lars Thim, Birgitte Wulff
  • Publication number: 20060240125
    Abstract: A composition for reducing the weight of a human. The composition is provided in the form of a capsule comprising an effective amount of capsaicin and/or analogs thereof, L-tyrosine, supplemental caffeine and/or and analogs thereof, green tea extract containing catechin and caffeine, and embodiments which include calcium. The invention is also directed toward methods for reducing and maintaining weight of a human using the composition.
    Type: Application
    Filed: April 21, 2005
    Publication date: October 26, 2006
    Inventors: Arne Astrup, Soren Toubro
  • Publication number: 20050214347
    Abstract: The invention relates to a low-energy-diet (LED) having effect on the basal metabolic rate, the protein metabolism and/or the energy expenditure, such as a low-energy-diet comprising Carbohydrate: 70-120 g, Protein: 50-80 g, Fat: 5-20 g, including medium chain triglycerides, and Iron: 20-30 mg/d, wherein the carbohydrate source and/or the fat source may increase the energy expenditure.
    Type: Application
    Filed: June 23, 2003
    Publication date: September 29, 2005
    Inventors: Arne Astrup, Soren Toubro
  • Patent number: 5422352
    Abstract: The present invention is directed to a method for reducing the weight of a human and a method for reducing the adipose tissue mass/lean mass body mass ratio of a human or a domestic animal. In each method, an effective dose of a combination of ephedrine and caffeine are administered in a weight ratio of about 1:12, respectively, calculated on the amount of ephedrine in the form of the free base.
    Type: Grant
    Filed: December 21, 1992
    Date of Patent: June 6, 1995
    Assignee: Nycomed Dak A/S
    Inventor: Arne Astrup